This year’s most read articles on respiratory cover topics on long-term health effects of COVID-19, adolescent vaping, and more.
The top 5 most-read respiratory articles and interviews on AJMC.com this year look at the most pressing issues, including long-term COVID-19, pneumonia, and long-term health effects of vaping.
Here are the most-viewed respiratory pieces in 2022.
5. Short-Course Antibiotic Therapy for Community-Acquired Pneumonia as Effective as Long-Course Therapy
A study published in the journal Clinical Microbiology and Infection found that short-course antibiotic therapy was just as effective as long-course therapy when comparing results in hospitalized patients with mild or moderate community-acquired pneumonia. Minimizing antibiotic use with short-course therapy addresses concerns regarding antimicrobial resistance to antibiotics. The real-world findings added to previous research, which mainly came from randomized controlled trials.
4. Nutrition, Pneumonia Severity May Predict Life Expectancy From Aspiration Pneumonia
Poor nutritional status and worse severity of pneumonia were associated with higher mortality rates in aspiration pneumonia, according to a study published in The Clinical Respiratory Journal. Additionally, men were found to have lower survival rates compared with women. When evaluating these risk factors for 90-day survival, the researchers found the non-survival group had higher disease severity, as measured by increased inflammation levels of C-reactive protein, white blood cell count, and dehydration and significantly higher nutritional disorders.
3. Vaping Injuries Associated With Long-term Respiratory Problems, Study Finds
Patients with e-cigarette or vaping-associated lung injury (EVALI) were found to have a higher risk of developing a disability that would keep them being able to work or pay bills, according to a study presented at the American Thoracic Society Meeting. Higher risk of cognitive impairment, depression, anxiety, and posttraumatic stress were found in patients within 1 year after EVALI.
2. COVID-19 Survivors at Increased Risk for Pulmonary Embolism, Respiratory Symptoms
People who were exposed to and infected with SARS-CoV-2 have twice the risk of developing pulmonary embolism or respiratory conditions, researchers found. When evaluating case patients to control patients, 38% of case patients experienced an incidence of pulmonary embolism or respiratory symptoms compared with 16% of control patients. The report was published in the CDC's Morbidity and Mortality Weekly Report.
1. Frequent Productive Cough Associated With Worse Outcomes in Asthma, COPD
Frequent productive cough was found to be an indicator of adverse outcomes for patients with asthma and/or chronic obstructive pulmonary disease (COPD). The prevalence of frequent productive cough increased with higher disease severity and was linked with significant disease burden. The study was published in in Respiratory Medicine.
Preventing Respiratory Illness and Death Through Tighter Air Quality Standards
June 1st 2021On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.
Listen
Are AI-Powered Robots the Future of Respiratory Health Care?
September 17th 2024Introducing artificial intelligence (AI)–powered robots like AMECA into health care comes with potential benefits like improved clinical decision-making and faster diagnoses, but also presents challenges such as misinformation risks and data privacy concerns.
Read More
Overcoming Failures: Lessons From IPF Clinical Trials in the Past Year
September 10th 2024Luca Richeldi, MD, PhD, outlined crucial lessons from recent idiopathic pulmonary fibrosis (IPF) trial failures, advocating for adaptive trial designs, rigorous statistical methods, and a focus on patient-relevant outcomes to enhance future research.
Read More